# 9 METERS BIOPHARMA, INC. 9 METERS BIOPHARMA, INC. is a company headquartered in Raleigh, NC, United States. ## Company overview - **Legal name:** 9 METERS BIOPHARMA, INC. - **Former names in filing history:** INNOVATE BIOPHARMACEUTICALS, INC. (2017-09-08 to 2020-05-05); Monster Digital, Inc. (2015-09-09 to 2018-01-11); Tandon Digital, Inc. (2012-06-19 to 2015-08-12) - **Classification:** Company - **Industry (SIC):** 2834 — Pharmaceutical Preparations - **Headquarters:** Raleigh, NC, United States - **Incorporated in:** DE - **Fiscal year end:** December 31 - **SEC CIK:** 0001551986 ## About 9 METERS BIOPHARMA, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001551986, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-28, it reported net income of USD -43,766,415; total assets of USD 33,147,844 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates. ## Financials Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million. ### FY2022 (period ended 2022-12-31) - **Net income:** -$43.8M (USD -43,766,415) - **Total assets:** $33.1M (USD 33,147,844) - **Cash and equivalents:** $12.6M (USD 12,646,282) - **Operating cash flow:** -$37.2M (USD -37,243,217) ### FY2021 (period ended 2021-12-31) - **Net income:** -$36.8M (USD -36,779,400) - **Total assets:** $50.2M (USD 50,173,525) - **Cash and equivalents:** $47.0M (USD 46,993,285) - **Operating cash flow:** -$29.5M (USD -29,478,275) ### FY2020 (period ended 2020-12-31) - **Net income:** -$61.5M (USD -61,496,489) - **Total assets:** $39.2M (USD 39,158,513) - **Operating cash flow:** -$19.4M (USD -19,409,786) ### FY2019 (period ended 2019-12-31) - **Net income:** -$27.0M (USD -27,048,808) - **Total assets:** $5.3M (USD 5,296,816) - **Operating cash flow:** -$18.0M (USD -17,967,992) ## Recent SEC filings - Form 8-K — filed 2023-07-18 — period 2023-07-17 - Form 8-K — filed 2023-06-16 — period 2023-06-12 — 8-K - Form 8-K — filed 2023-05-30 — period 2023-05-26 — 8-K - Form 8-K — filed 2023-05-22 — period 2023-05-19 — 8-K - Form 8-K — filed 2023-05-19 — period 2023-05-18 — 8-K - Form 10-Q — filed 2023-05-15 — period 2023-03-31 — 10-Q - Form 8-K — filed 2023-05-15 — period 2023-05-15 — 8-K - Form 10-K/A — filed 2023-04-28 — period 2022-12-31 — 10-K/A - Form 8-K — filed 2023-04-27 — period 2023-04-26 — 8-K - Form 8-K — filed 2023-04-06 — period 2023-03-31 — 8-K - Form 8-K — filed 2023-04-05 — period 2023-04-05 - Form 10-K — filed 2023-03-28 — period 2022-12-31 — 10-K --- Updated: 2026-10-23T20:06:36Z Canonical page: https://altss.com/profile/9-meters-biopharma-inc Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology